Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Phase 3 data will be required to support any future regulatory submission
13, 1109651 (2023) Lorcaserin, (Belviq) E.A
It has a forward price-to-earnings (P/E) ratio of 36.5 times 2025 analyst estimates, but a price-to-earnings-to-growth (PEG) ratio of under 0.4
Wanting is typically measured using food craving scales, cue-reactivity paradigms, and assessments of reward sensitivity (33, 34)
Gargalo CL, Udugama I, Pontius K, Lopez PC, Nielsen RF, Hasanzadeh A, Mansouri SS, Bayer C, Junicke H, Gernaey KV
US$ 26.88
US$ 27.05
US$ 21.82
US$ 28.15
US$ 26.80
US$ 26.07
US$ 27.06
US$ 21.51
US$ 29.31
